Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-arginine supplementation in severe fever with thrombocytopenia syndrome
ChiCTR-IPR-17012288Phase 4Recruiting
- Sponsor
- State Key Laboratory of Pathogen and Biosecurity
- Start
- Aug 2017
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of arginine in severe fever with thrombocytopenia syndrome (SFTS) (2 arms), sponsored by State Key Laboratory of Pathogen and Biosecurity. Primary endpoints: Mortality rate, Severity rate and 3 more. Started Aug 2017; status: recruiting.
02
Drugs
arginine
03
Conditions
severe fever with thrombocytopenia syndrome (SFTS)
Beyond the preview
Go deeper on ChiCTR-IPR-17012288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17012288.